Guillain-Barre Risk Up Slightly After Shingrix

(MedPage Today) -- Risk of Guillain-Barré syndrome (GBS) increased slightly after receiving the recombinant zoster vaccine (RZV; Shingrix), Medicare claims data showed.
In the 42 days after vaccination, researchers found approximately three...